These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Outcome of transsphenoidal surgery for Cushing's disease: a high remission rate in ACTH-secreting macroadenomas. Fomekong E; Maiter D; Grandin C; Raftopoulos C Clin Neurol Neurosurg; 2009 Jun; 111(5):442-9. PubMed ID: 19200645 [TBL] [Abstract][Full Text] [Related]
4. Pituitary magnetic resonance imaging findings do not influence surgical outcome in adrenocorticotropin-secreting microadenomas. Salenave S; Gatta B; Pecheur S; San-Galli F; Visot A; Lasjaunias P; Roger P; Berge J; Young J; Tabarin A; Chanson P J Clin Endocrinol Metab; 2004 Jul; 89(7):3371-6. PubMed ID: 15240617 [TBL] [Abstract][Full Text] [Related]
5. Crooke's Changes In Cushing's Syndrome Depends on Degree of Hypercortisolism and Individual Susceptibility. Oldfield EH; Vance ML; Louis RG; Pledger CL; Jane JA; Lopes MB J Clin Endocrinol Metab; 2015 Aug; 100(8):3165-71. PubMed ID: 26147609 [TBL] [Abstract][Full Text] [Related]
6. A critical evaluation of transsphenoidal pituitary surgery in the treatment of Cushing's disease: prediction of outcome. Arnott RD; Pestell RG; McKelvie PA; Henderson JK; McNeill PM; Alford FP Acta Endocrinol (Copenh); 1990 Oct; 123(4):423-30. PubMed ID: 2173325 [TBL] [Abstract][Full Text] [Related]
7. Transsphenoidal surgery for Cushing's disease: endocrinological follow-up monitoring of 82 patients. Shimon I; Ram Z; Cohen ZR; Hadani M Neurosurgery; 2002 Jul; 51(1):57-61; discussion 61-2. PubMed ID: 12182435 [TBL] [Abstract][Full Text] [Related]
8. Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome? Chee GH; Mathias DB; James RA; Kendall-Taylor P Clin Endocrinol (Oxf); 2001 May; 54(5):617-26. PubMed ID: 11380492 [TBL] [Abstract][Full Text] [Related]
9. Transsphenoidal surgery for Cushing's disease: does what is removed determine the endocrine outcome? Burke CW; Adams CB; Esiri MM; Morris C; Bevan JS Clin Endocrinol (Oxf); 1990 Oct; 33(4):525-37. PubMed ID: 2171817 [TBL] [Abstract][Full Text] [Related]
10. Cushing's disease in a child caused by a corticotropin-releasing hormone-secreting intrasellar gangliocytoma associated with an adrenocorticotropic hormone-secreting pituitary adenoma. Puchner MJ; Lüdecke DK; Valdueza JM; Saeger W; Willig RP; Stalla GK; Odink RJ Neurosurgery; 1993 Nov; 33(5):920-4; discussion 924-5. PubMed ID: 8264895 [TBL] [Abstract][Full Text] [Related]
11. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease. Flitsch J; Knappe UJ; Lüdecke DK Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940 [TBL] [Abstract][Full Text] [Related]
12. Surgical remission of pituitary adenomas confined to the neurohypophysis in Cushing's disease. Weil RJ; Vortmeyer AO; Nieman LK; Devroom HL; Wanebo J; Oldfield EH J Clin Endocrinol Metab; 2006 Jul; 91(7):2656-64. PubMed ID: 16636117 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847 [TBL] [Abstract][Full Text] [Related]
14. Does an analysis of the pulsatile secretion pattern of adrenocorticotropin and cortisol predict the result of transsphenoidal surgery in Cushing's disease? Buchfelder M; Fahlbusch R; Wentzlaff-Eggebert H; Brabant G; Stalla GK; Müller OA J Clin Endocrinol Metab; 1993 Sep; 77(3):720-4. PubMed ID: 8396575 [TBL] [Abstract][Full Text] [Related]
15. Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up. Bakiri F; Tatai S; Aouali R; Semrouni M; Derome P; Chitour F; Benmiloud M J Endocrinol Invest; 1996 Oct; 19(9):572-80. PubMed ID: 8957739 [TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing's disease. Schrell U; Fahlbusch R; Buchfelder M; Riedl S; Stalla GK; Müller OA J Clin Endocrinol Metab; 1987 Jun; 64(6):1150-9. PubMed ID: 3033006 [TBL] [Abstract][Full Text] [Related]
17. Selective excision of adenomas originating in or extending into the pituitary stalk with preservation of pituitary function. Mason RB; Nieman LK; Doppman JL; Oldfield EH J Neurosurg; 1997 Sep; 87(3):343-51. PubMed ID: 9285597 [TBL] [Abstract][Full Text] [Related]
18. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Mukherjee A; Murray RD; Teasdale GM; Shalet SM Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963 [TBL] [Abstract][Full Text] [Related]
19. Anterior pituitary function after transsphenoidal selective adenomectomy in patients with Cushing's disease. Kuwayama A; Kageyama N; Nakane T; Watanabe M; Kanie N J Clin Endocrinol Metab; 1981 Jul; 53(1):165-73. PubMed ID: 6263935 [TBL] [Abstract][Full Text] [Related]
20. Pituitary pathology in Cushing's disease. Histology and morphometry of pituitary tissues removed through microsurgery. Olivier L; Vila-Porcile E Pathol Res Pract; 1988 Sep; 183(5):587-91. PubMed ID: 3237548 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]